Gregory R Tintinger Selected Research

Pneumonia (Pneumonitis)

1/2021

Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory R Tintinger Research Topics

Disease

3	Inflammation (Inflammations) 12/2022 - 02/2009
3	Chronic Obstructive Pulmonary Disease (COPD) 05/2015 - 12/2010
2	Infections 01/2021 - 01/2014
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 01/2018
2	Cardiotoxicity 01/2020 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Asthma (Bronchial Asthma) 01/2013 - 12/2010
1	Obesity 12/2022
1	Weight Gain 12/2022
1	Insulin Resistance 12/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2022
1	Neoplasms (Cancer) 01/2021
1	Neutropenia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Sepsis (Septicemia) 01/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019
1	HIV Infections (HIV Infection) 01/2016
1	Rheumatoid Arthritis 05/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Aspirin-Induced Asthma 12/2010
1	Cystic Fibrosis (Mucoviscidosis) 12/2010
1	Viral Bronchiolitis 12/2010

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2015
2	CytokinesIBA 01/2019 - 05/2015
1	HIV IntegraseIBA 12/2022
1	dolutegravirIBA 12/2022
1	atezolizumabIBA 01/2021
1	avelumabIBA 01/2021
1	durvalumabIBA 01/2021
1	cemiplimabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AntigensIBA 01/2021
1	LigandsIBA 01/2021
1	bedaquiline (R207910)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Clofazimine (Lamprene)FDA Link 01/2018
1	HIV AntibodiesIBA 01/2016
1	Antirheumatic Agents (DMARD)IBA 05/2015
1	Anti-Citrullinated Protein AntibodiesIBA 05/2015
1	Formoterol Fumarate (Oxis)FDA Link 05/2015
1	Bronchodilator Agents (Bronchodilators)IBA 01/2013
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 12/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2010
1	montelukast (Singulair)FDA Link 12/2010
1	CalciumIBA 02/2009

Therapy/Procedure

3	Therapeutics 05/2015 - 12/2010
1	Immunotherapy 01/2021
1	Radiotherapy 01/2021
1	Drug Therapy (Chemotherapy) 12/2010